Synapse - Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes

Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes Research Letter

Authors:	Lue, J. K.; Luttwak, E.; Rivas-Delgado, A.; Irawan, H.; Boardman, A.; Caron, P. C.; David, K.; Epstein-Peterson, Z.; Falchi, L.; Ghione, P.; Hamlin, P.; Horwitz, S. M.; Intlekofer, A. M.; Johnson, W.; Kumar, A.; Moskowitz, A.; Noy, A.; Palomba, M. L.; Steiner, R.; Stuver, R.; Torka, P.; Vardhana, S.; Zelenetz, A. D.; Schoder, H.; Imber, B.; Yahalom, J.; Zhang, Y.; Galera, P.; Dogan, A.; Aypar, U.; Salles, G.
Title:	Limited stage high grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangements: BCL2 rearrangements drives the poor outcomes
Keywords:	adult; cancer survival; aged; aged, 80 and over; middle aged; gene mutation; genetics; cancer patient; cancer grading; letter; protein bcl 2; pathology; b cell lymphoma; lymphoma, b-cell; gene rearrangement; myc protein; protein bcl 6; myc protein, human; proto-oncogene proteins c-myc; proto-oncogene proteins c-bcl-2; clinical outcome; proto-oncogene proteins c-bcl-6; neoplasm grading; very elderly; humans; prognosis; human; male; female; bcl2 protein, human; bcl6 protein, human
Journal Title:	Blood Cancer Journal
Volume:	14
ISSN:	2044-5385
Publisher:	Nature Publishing Group
Date Published:	2024-10-14
Start Page:	178
Language:	English
DOI:	10.1038/s41408-024-01148-x
PUBMED:	39402034
PROVIDER:	scopus
PMCID:	PMC11473722
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85206275970&doi=10.1038%2fs41408-024-01148-x&partnerID=40&md5=232abf3a2532fd9f892e3003e1776c0d
Notes:	Letter -- MSK Cancer Center Support Group (P30 CA008748) acknowledged in PubMed and PDF -- MSK corresponding author is Jennifer Lue -- Source: Scopus